Dextroamphetamine Sulfate
Pricing Report NDC 64720-327-09

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Dextroamphetamine Sulfate (NDC 64720-327-09) is $2.52611 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2015.

As a provided by Corepharma, Llc, this medication is distributed in a 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.52611
Per EA

Effective Date
Aug 19, 2015
Billable Units
90 EA
Estimated Package Price
$227.35
Data Status
As of Sep 16, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $2.39333 to $2.92034 per EA. Over this 1 year and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.3933 - $2.9203
Market Volatility
22.02% Variance
Latest Trend
5.55%
Date Unit Price Unit Source Method Rate
Aug 19, 2015 $2.52611 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2015 $2.39333 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2015 $2.70994 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2015 $2.70994 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 22, 2015 $2.92034 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2015 $2.90439 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2014 $2.70166 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2014 $2.70166 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 19, 2014 $2.42646 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $2.68481 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $2.68481 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 23, 2014 $2.78558 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $2.72827 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $2.64826 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $2.63298 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $2.80451 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $2.78908 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $2.81419 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $2.89195 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2013 $2.83818 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026